Skip to main content
. 2019 Mar 12;10(21):2030–2040. doi: 10.18632/oncotarget.26771

Figure 2. Kaplan–Meier survival.

Figure 2

High TIM-3 expression on DLBCL tumor cells correlates with inferior progression-free survival (PFS) with 4-year PFS 23% vs 60%, respectively, P = 0.008 and overall survival (OS) with 4-year OS 30% vs 74%, respectively, P = 0.006.

HHS Vulnerability Disclosure